V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330005405 | 330002582 | 1.7 | 52 | Curative (C) | 2018-05-26 | 2018-05-26 | FLAG + Idarubicin | 02 | null | 330023336 | ECARBOX |
| 330005406 | 330002582 | 1.56 | 61 | Adjuvant (A) | 2014-08-22 | 2014-08-25 | EOX | N | N | 330023336 | TEMOZOLOMIDE + RT |
| 330005407 | 330002582 | 1.68 | 77.9 | null | 2013-09-15 | 2013-09-17 | CNS LGG 2004 03 vinc weekly+ carbo | N | null | 330023336 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE |
| 330005408 | 330002582 | 1.64 | null | Palliative (P) | 2016-03-24 | 2016-03-24 | Docetaxel+Gemcitabine (no prior RT) | 02 | null | 330023336 | CAPECITABINE + CARBOPLATIN |
| 330005409 | 330002582 | 1.77 | 50.9 | null | 2014-01-22 | 2014-01-23 | Azacitidine | 99 | N | 330023336 | PEMBROLIZUMAB |
| 330005410 | 330002583 | 1.5 | 25.5 | Curative (C) | 2015-09-09 | 2015-09-09 | Cyclophosphamide + Vincristine | N | N | 330023349 | PACLITAXEL |
| 330005411 | 330002584 | 1.78 | 86.5 | Disease modification (D) | 2015-06-24 | 2015-10-02 | AML Int Guide ADE 10+3+5 (1) | N | N | 330023352 | CHLORAMBUCIL + OFATUMUMAB |
| 330005412 | 330002585 | 0.77 | 8.7 | T | 2013-02-12 | 2013-02-12 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | 330023353 | FLAG + IDARUBICIN |
| 330005413 | 330002586 | 2.05 | null | Disease modification (D) | 2018-04-16 | 2018-05-03 | CAPECITABINE + CARBOPLATIN | N | Y | 330023355 | VINBLASTINE |
| 330005414 | 330002587 | 1.71 | null | Adjuvant (A) | 2016-05-15 | 2016-05-28 | Dacarbazine | 2 | N | 330023358 | CARBOPLATIN + VINCRISTINE |
| 330005415 | 330002588 | 1.68 | 61.7 | Palliative (P) | null | 2015-06-21 | Azacitidine | N | N | 330023359 | HYDROXYCARBAMIDE |
| 330005416 | 330002589 | 1.7 | 90.4 | Adjuvant (A) | 2017-04-03 | 2017-04-04 | UKALL14- Ph 1 Induction + Imatinib | N | N | 330023366 | BORTEZOMIB |
| 330005417 | 330002589 | 1.7 | 79.6 | Disease modification (D) | null | 2013-07-10 | Capecitabine + Cisplatin | N | N | 330023366 | UKALL60+ |
| 330005418 | 330002590 | null | 0 | Adjuvant (A) | 2017-11-15 | 2017-12-02 | METHOTREXATE | N | null | 330023374 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 330005419 | 330002590 | 0 | 12.4 | null | 2017-04-01 | 2017-04-01 | DOCETAXEL + GEMCITABINE | 02 | null | 330023374 | FCR |
| 330005420 | 330002591 | null | null | Curative (C) | 2013-01-23 | 2013-01-23 | ADE | N | null | 330023379 | METHOTREXATE |
| 330005421 | 330002592 | 1.76 | 0 | null | 2015-09-27 | 2015-10-11 | Chlorambucil + Pred + Rituximab | N | N | 330023403 | CYTARABINE HIGH DOSE |
| 330005422 | 330002592 | 1.14 | 7.9 | Palliative (P) | 2013-05-25 | 2013-06-16 | IMATINIB | N | N | 330023403 | CHLORAMBUCIL |
| 330005423 | 330002593 | 1.8 | 56.4 | Curative (C) | 2017-03-01 | 2017-03-01 | CAPECITABINE + CARBOPLATIN + Cetuximab | 1 | N | 330023408 | CYTARABINE |
| 330005424 | 330002594 | null | 84.9 | Curative (C) | 2014-04-23 | 2014-05-02 | CARBOPLATIN + RT | N | null | 330023409 | HYDROXYCARBAMIDE |
| 330005425 | 330002595 | 1.63 | 76 | null | 2017-04-30 | 2017-05-12 | Cytarabine Low Dose | 02 | N | 330023410 | MITOTANE |
| 330005426 | 330002596 | 1.69 | 71.9 | Curative (C) | 2013-02-10 | 2013-02-10 | Chlorambucil | 02 | N | 330023411 | PACLITAXEL |
| 330005427 | 330007420 | 1.64 | 71.2 | Curative (C) | 2013-07-30 | 2013-08-05 | Dacarbazine | N | N | 330023417 | PACLITAXEL |
| 330005428 | 330007420 | 1.77 | 62.8 | Curative (C) | 2013-09-18 | 2013-09-19 | BORTEZOMIB + RITUXIMAB | N | N | 330023417 | CAV |
| 330005429 | 330002597 | 1.61 | 0 | Palliative (P) | 2016-11-02 | 2016-11-04 | Vincristine (weekly) | Y | N | 330023430 | CYTARABINE |
| 330005430 | 330002597 | 1.86 | null | Adjuvant (A) | 2013-04-19 | 2013-04-19 | Chlorambucil | 2 | N | 330023430 | BEVACIZUMAB |
| 330005431 | 330002598 | 0 | 83.6 | Curative (C) | 2016-08-30 | 2016-08-30 | Paclitaxel (2 or 3 weekly) | 1 | N | 330023440 | CYTARABINE |
| 330005432 | 330002598 | 1.72 | 68.2 | Adjuvant (A) | 2018-03-01 | 2018-03-04 | CNS Low Grade Glioma Vinblastine | N | N | 330023440 | CISPLATIN + DOCETAXEL |
| 330005433 | 330010029 | 1.56 | 90 | Palliative (P) | 2014-04-18 | 2014-04-19 | ALL UKALL2011 Ind B Sht Dex (PAsp) | N | N | 330023454 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE |
| 330005434 | 330010029 | null | 91.4 | Curative (C) | null | 2015-07-21 | DOCETAXEL + GEMCITABINE | null | null | 330023454 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 330005435 | 330010029 | 1.52 | 85 | Adjuvant (A) | 2016-03-12 | 2016-03-13 | MITOTANE | 02 | N | 330023454 | CHLORAMBUCIL |
| 330005436 | 330012710 | null | null | Not known (9) | 2015-01-14 | 2015-01-19 | AML16 DA 3+10 | N | N | 330023465 | AZACITIDINE |
| 330005441 | 330002600 | 1.65 | 11.9 | Curative (C) | 2013-02-03 | 2013-02-14 | ADE 10+3+5 | N | N | 330023488 | VAI |
| 330005442 | 330002601 | null | null | Palliative (P) | 2016-07-06 | 2016-07-25 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 330023492 | CISPLATIN + DOXORUBICIN + ETOPOSIDE |
| 330005443 | 330002602 | 1.65 | 49.8 | Curative (C) | 2014-10-07 | 2014-10-23 | UKALL14- Ph 1 Induction | N | N | 330023501 | ETOPOSIDE + IFOSFAMIDE |
| 330005444 | 330002603 | null | null | Curative (C) | 2016-04-28 | 2016-05-08 | Cisplatin+Doxorubicin+Etoposide 28d | N | N | 330023502 | FLUOROURACIL + MITOMYCIN + RT |
| 330005446 | 330002605 | null | 78.7 | Neo-adjuvant (N) | null | 2013-10-23 | MIFAMURTIDE | null | null | 330023516 | PEMBROLIZUMAB |
| 330005447 | 330007424 | null | 55.8 | Curative (C) | null | 2015-07-06 | Azacitidine | null | null | 330023517 | CHLORAMBUCIL + RITUXIMAB |
| 330005448 | 330002606 | null | 62 | Curative (C) | 2013-09-20 | 2013-11-09 | VIDE | 02 | N | 330023522 | IPILIMUMAB |
| 330005449 | 330002607 | null | 68 | Curative (C) | 2016-04-30 | 2016-05-04 | EDP | 02 | null | 330023525 | IMATINIB |
| 330005450 | 330002607 | 1.83 | 90 | Neo-adjuvant (N) | 2014-10-22 | 2014-11-05 | Etoposide + Ifosfamide (3 days) | N | y | 330023525 | CHOP |
| 330005451 | 330002607 | 1.77 | 41.7 | Palliative (P) | 2015-01-05 | 2015-01-13 | CAPECITABINE + IRINOTECAN | N | N | 330023525 | CISPLATIN + DOCETAXEL |
| 330005452 | 330002608 | 1.7 | 101.9 | Not known (9) | 2016-06-11 | 2016-06-19 | Azacitidine | 02 | null | 330023533 | EOX |
| 330005453 | 330002608 | 1.7 | 87.6 | Palliative (P) | 2013-09-07 | 2013-09-10 | RUXOLITINIB | 02 | null | 330023533 | FCR |
| 330005454 | 330002609 | 1.6 | 62.8 | Palliative (P) | 2017-05-18 | 2017-05-29 | ATG + Busulfan + Fludarabine | 02 | N | 330023548 | UKALL2011 |
| 330005455 | 330007427 | 1.66 | 98.5 | Curative (C) | 2014-01-05 | 2014-01-12 | RUXOLITINIB | N | N | 330023549 | AML18 TRIAL |
| 330005456 | 330002610 | 1.74 | 90 | Palliative (P) | 2016-01-26 | 2016-02-02 | CARBOPLATIN + RT | N | N | 330023555 | CISPLATIN + CYCLO + DOXORUBICIN |
| 330005457 | 330007428 | 1.75 | 101 | Curative (C) | 2013-10-15 | 2013-11-11 | IMATINIB | 2 | Y | 330023561 | VINBLASTINE |
| 330005458 | 330002611 | 0 | 34.1 | Curative (C) | 2015-12-26 | 2015-12-31 | CNS Low Grade Glioma Vinblastine | 2 | N | 330023563 | PEMBROLIZUMAB |
| 330005459 | 330002612 | 0 | 102 | Curative (C) | 2014-11-18 | 2014-11-23 | Sunitinib | 2 | N | 330023571 | EVEROLIMUS |